trending Market Intelligence /marketintelligence/en/news-insights/trending/cFrBxVZQhw1-hU0Bo-gANg2 content esgSubNav
In This List

Sisram Medical offering underwriters exercise overallotment option

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Sisram Medical offering underwriters exercise overallotment option

Underwriters in Sisram Medical Ltd.'s global offering exercised their option to buy an additional 2,155,600 shares at HK$8.88 apiece, raising about HK$18.3 million in additional net proceeds.

Following the underwriters' partial exercise of their overallotment option, the indirect interest of Sisram Medical's parent companies, Shanghai Fosun Pharmaceutical (Group) Co. Ltd. and Fosun International Ltd., decreased to about 52.70% from about 52.96%.